在欧洲赋予癌症研究权力:EUCAIM癌症成像基础设施
Luis Martí-Bonmatí1, Ignacio Blanquer2, Manolis Tsiknakis3
1Biomedical Imaging Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain. luis_marti@iislafe.es.
Insights into imaging
|February 24, 2025
概括
欧盟欧洲癌症成像联合会 (EUCAIM) 项目为癌症成像数据创建了一个联合的基础设施. 这种基础设施解决了数据碎片化和隐私问题,推动了癌症研究中的AI发展.
科学领域:
- 在瘤学瘤学.
- 医疗成像医学成像
- 人工智能的人工智能
背景情况:
- 人工智能 (AI) 开发用于癌症检测,诊断和治疗需要大型,复杂,现实世界的数据集.
- 数据碎片化,异质性,缺乏注释和隐私问题限制了对这些关键数据集的访问.
- 欧洲癌症成像倡议旨在通过癌症图像的联合欧洲基础设施来克服这些障碍.
研究的目的:
- 通过欧盟资助的欧盟欧洲癌症影像联合会 (EUCAIM) 项目建立一个名为"欧洲癌症影像"的癌症影像数据联合欧洲基础设施.
- 为临床医生,研究人员和创新者提供开发和验证基于人工智能的临床决策系统的手段.
- 通过共同的数据模型,质量标准和FAIR原则的遵守,确保数据质量,互操作性,一致性和隐私.
主要方法:
- 在AI for Health Imaging网络 (AI4HI) 和已建立的欧洲研究基础设施 (Euro-BioImaging,BBMRI-ERIC,EATRIS,ECRIN,ELIXIR) 的基础上.
- 实施共同的数据模型,链接超本事学,质量标准和遵守FAIR原则.
- 提供数据注释,策划和匿名化服务,以及用于安全数据处理和分析的联合基础设施.
主要成果:
- 在2024年夏天,EUCAIM项目发布了欧盟范围基础设施的第一个原型.
- 该基础设施具有全面的仪表板,用于数据集发现,联合搜索,数据访问请求和元数据收集.
- 它集成了安全的处理环境和联合处理能力,用于人工智能开发.
结论:
- 针对癌症图像数据的EUCAIM联合基础设施在欧洲大大推动了医学研究和人工智能开发.
- 它有效地解决了数据碎片化和异质性问题,同时确保法律遵守并促进合作.
- 该计划通过提供各种数据类型和先进的研究工具来加强癌症研究.
相关概念视频
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...